Calabrese C - Search Results

1

Evolution of the Clinical Profile and Outcomes of Unvaccinated Patients Affected by Critical COVID-19 Pneumonia from the Pre-Vaccination to the Post-Vaccination Waves in Italy.

Calabrese C, Annunziata A, Mariniello DF, Coppola A, Mirizzi AI, Simioli F, Pelaia C, Atripaldi L, Pugliese G, Guarino S, Fiorentino G. Calabrese C, et al. Pathogens. 2022 Jul 14;11(7):793. doi: 10.3390/pathogens11070793. Pathogens. 2022. PMID: 35890037 Free PMC article.

2

Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma.

Pelaia C, Calabrese C, Vatrella A, Busceti MT, Garofalo E, Lombardo N, Terracciano R, Pelaia G. Pelaia C, et al. Among authors: calabrese c. Biomed Res Int. 2018 May 10;2018:4839230. doi: 10.1155/2018/4839230. eCollection 2018. Biomed Res Int. 2018. PMID: 29862274 Free PMC article. Review.

3

Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.

Pelaia C, Calabrese C, Terracciano R, de Blasio F, Vatrella A, Pelaia G. Pelaia C, et al. Among authors: calabrese c. Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618810192. doi: 10.1177/1753466618810192. Ther Adv Respir Dis. 2018. PMID: 30400762 Free PMC article. Review.

4

Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study.

Pelaia C, Calabrese C, Barbuto S, Busceti MT, Preianò M, Gallelli L, Savino R, Vatrella A, Pelaia G. Pelaia C, et al. Among authors: calabrese c. Pulm Pharmacol Ther. 2019 Feb;54:25-30. doi: 10.1016/j.pupt.2018.11.002. Epub 2018 Nov 7. Pulm Pharmacol Ther. 2019. PMID: 30414440

5

Switching from omalizumab to mepolizumab: real-life experience from Southern Italy.

Carpagnano GE, Pelaia C, D'Amato M, Crimi N, Scichilone N, Scioscia G, Resta O, Calabrese C, Pelaia G, Quarato CMI, Foschino Barbaro MP. Carpagnano GE, et al. Among authors: calabrese c. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620929231. doi: 10.1177/1753466620929231. Ther Adv Respir Dis. 2020. PMID: 32482128 Free PMC article.

6

Basophil activation test for Staphylococcus aureus enterotoxins in severe asthmatic patients.

Flora M, Perna F, Abbadessa S, Garziano F, Maffucci R, Maniscalco M, Mollica M, Pelaia C, Tremante E, Maffei M, Calabrese C. Flora M, et al. Among authors: calabrese c. Clin Exp Allergy. 2021 Apr;51(4):536-545. doi: 10.1111/cea.13772. Epub 2020 Nov 12. Clin Exp Allergy. 2021. PMID: 33131112

7

Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19.

Caterino M, Gelzo M, Sol S, Fedele R, Annunziata A, Calabrese C, Fiorentino G, D'Abbraccio M, Dell'Isola C, Fusco FM, Parrella R, Fabbrocini G, Gentile I, Andolfo I, Capasso M, Costanzo M, Daniele A, Marchese E, Polito R, Russo R, Missero C, Ruoppolo M, Castaldo G. Caterino M, et al. Among authors: calabrese c. Sci Rep. 2021 Feb 3;11(1):2941. doi: 10.1038/s41598-021-82426-7. Sci Rep. 2021. PMID: 33536486 Free PMC article.

8

ACE Gene I/D Polymorphism and Acute Pulmonary Embolism in COVID19 Pneumonia: A Potential Predisposing Role.

Calabrese C, Annunziata A, Coppola A, Pafundi PC, Guarino S, Di Spirito V, Maddaloni V, Pepe N, Fiorentino G. Calabrese C, et al. Front Med (Lausanne). 2021 Jan 21;7:631148. doi: 10.3389/fmed.2020.631148. eCollection 2020. Front Med (Lausanne). 2021. PMID: 33585520 Free PMC article.

9

Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression.

Pelaia C, Crimi C, Benfante A, Caiaffa MF, Calabrese C, Carpagnano GE, Ciotta D, D'Amato M, Macchia L, Nolasco S, Pelaia G, Pellegrino S, Scichilone N, Scioscia G, Spadaro G, Valenti G, Vatrella A, Crimi N. Pelaia C, et al. Among authors: calabrese c. J Asthma Allergy. 2021 Feb 22;14:163-173. doi: 10.2147/JAA.S297273. eCollection 2021. J Asthma Allergy. 2021. PMID: 33654413 Free PMC article.

10

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma.

Carpagnano GE, Resta E, Povero M, Pelaia C, D'Amato M, Crimi N, Scichilone N, Scioscia G, Resta O, Calabrese C, Pelaia G, Barbaro MPF. Carpagnano GE, et al. Among authors: calabrese c. Sci Rep. 2021 Mar 9;11(1):5453. doi: 10.1038/s41598-021-84895-2. Sci Rep. 2021. PMID: 33750842 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

685 results

Search Page